Clinical Trials in South Gate, California
2 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 3
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Atrial Fibrillation (AF)
Anthos Therapeutics, Inc.1,900 enrolled734 locationsNCT05712200
Recruiting
Phase 1
Study of BHV-1300 in Graves' Disease
Graves Disease
Biohaven Therapeutics Ltd.15 enrolled13 locationsNCT06980649